Customer Story
From uncertainty to 100% approval: How innoscripta supported E. Wehrle GmbH’s research allowance claims
Reliable partner throughout the application
Consistently approved funding applications
Industry
Industrial Manufacturing
Company Size
Medium-Sized Enterprise
Location
Furtwangen, Germany
“With innoscripta, we have found a partner who supported us and guided us through the process in a structured and efficient manner. Thanks to our collaboration with innoscripta, our approval rate is currently 100%.”
Meet E. Wehrle GmbH
Wehrle is a long-established industrial company founded in the year 1842, with deep roots in precision engineering. Presently, their success is built on two core pillars: flowmetering technology and precision plastic materials. These competencies are reflected in their two business units, METERING and PRECISION PLASTICS, introduced in 2013.
With a workforce consisting of around 270 employees and a production area exceeding 10,000 m², Wehrle develops and manufactures reliable solutions for consumption control of fluids and high-quality, cost-effective plastic precision products. The company’s expertise evolved from the precision demands of clockmaking to water meter components in the 1930s, and later to plastic injection moulding in 1950.
The challenge: Navigating unfamiliar funding terrain
As an internationally active manufacturer, they had potential innovative projects, and the uncertainty Wehrle faced arose from the complexities involved in approaching the topic of research allowance. The demanding application process and the lack of internal experience made it difficult to pursue the opportunity with confidence.
The solution: Structured guidance and a smart software platform
By partnering with innoscripta, Wehrle gained systematic and holistic support throughout the funding process. The combination of hands-on consulting and the software platform Clusterix offered by innoscripta paved the road for efficient processes with simplified documentation and led to a successful submission of research allowance claims for several R&D projects.
The impact: Tangible results and long-term value
The collaboration with innoscripta brought remarkable results for Wehrle with the notable aspect being the 100% approval rate for research allowance claims and refinancing parts of their innovation costs. The streamlined process and consistently professional cooperation made innoscripta a trusted partner for Wehrle, and they highlight it by recommending innoscripta without reservation for organisations focusing on exploring government-backed R&D funding.
